Tag: Duty of Care
After Netherlands and Israel, now Italy: Leadiant fined for excessive price
FtV Projectcoordinator -
Bergeijk, June 2, 2022
The Italian Competition Authority (ICA) decided on 31 May that pharmaceutical company Leadiant has charged the Italian National Health Service excessive prices for the life-saving medicine Chenodeoxycholic acid (CDCA), and issued a fine of €3.5million.
“We believe that pharmaceutical companies have a duty of care to make...
Find the original (Dutch) article here.
Gerard Schouw responded on April 21 to the column by Marcel Levi, who two weeks earlier called for people to stop wasting money on excessively priced medicines. Schouw blames Levi for a flawed analysis and claims to refute this with figures: 'The share...